Repression of E-cadherin by the Polycomb Group Protein EZH2 in Cancer

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2008 Sep 23

PMID 18806826

Citations 310

Authors

Q Cao

S M Dhanasekaran

J H Kim

R-S Mani

S A Tomlins

R Mehra

B Laxman

X Cao

J Yu

C G Kleer

S Varambally

A M Chinnaiyan

Affiliations

Soon will be listed here.

Abstract

Enhancer of zeste homolog 2 (EZH2) is a critical component of the polycomb-repressive complex 2 (PRC2), which is involved in gene silencing and histone H3 lysine 27 methylation. EZH2 has a master regulatory function in controlling such processes as stem cell differentiation, cell proliferation, early embryogenesis and X chromosome inactivation. Although benign epithelial cells express very low levels of EZH2, increased levels of EZH2 have been observed in aggressive solid tumors such as those of the prostate, breast and bladder. The mechanism by which EZH2 mediates tumor aggressiveness is unclear. Here, we demonstrate that EZH2 mediates transcriptional silencing of the tumor suppressor gene E-cadherin by trimethylation of H3 lysine 27. Histone deacetylase inhibitors can prevent EZH2-mediated repression of E-cadherin and attenuate cell invasion, suggesting a possible mechanism that may be useful for the development of therapeutic treatments. Taken together, these observations provide a novel mechanism of E-cadherin regulation and establish a functional link between dysregulation of EZH2 and repression of E-cadherin during cancer progression.

Citing Articles

Polycomb repressive complex 2 (PRC2) pathway's role in cancer cell plasticity and drug resistance.

Goleij P, Heidari M, Tabari M, Hadipour M, Rezaee A, Javan A Funct Integr Genomics. 2025; 25(1):53.

PMID: 40048009 DOI: 10.1007/s10142-025-01563-8.

CBX2 suppresses interferon signaling to diminish tumor immunogenicity via a noncanonical corepressor complex.

Lin Y, Jin H, She Y, Zhang Y, Cui L, Xie C Proc Natl Acad Sci U S A. 2025; 122(5):e2417529122.

PMID: 39883845 PMC: 11804501. DOI: 10.1073/pnas.2417529122.

NSD3 protein methylation and stabilization transforms human ES cells into variant state.

Krishnamoorthy V, Hamdani F, Shukla P, Rao R, Anaitullah S, Biligiri K Life Sci Alliance. 2024; 8(3.

PMID: 39741006 PMC: 11707394. DOI: 10.26508/lsa.202402871.

Integration of epigenomic and transcriptomic profiling uncovers EZH2 target genes linked to cysteine metabolism in hepatocellular carcinoma.

Lee J, You C, Kwon G, Noh J, Lee K, Kim K Cell Death Dis. 2024; 15(11):801.

PMID: 39516467 PMC: 11549485. DOI: 10.1038/s41419-024-07198-0.

EZH2 inhibition or genetic ablation suppresses cyst growth in autosomal dominant polycystic kidney disease.

Lv J, Lan B, Fu L, He C, Zhou W, Wang X J Transl Med. 2024; 22(1):979.

PMID: 39472935 PMC: 11520870. DOI: 10.1186/s12967-024-05785-5.

References

van der Vlag J, Otte A . Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat Genet. 1999; 23(4):474-8. DOI: 10.1038/70602. View

Hajra K, Ji X, Fearon E . Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene. 1999; 18(51):7274-9. DOI: 10.1038/sj.onc.1203336. View

Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J . The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000; 2(2):84-9. DOI: 10.1038/35000034. View

Wijnhoven B, Dinjens W, Pignatelli M . E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg. 2000; 87(8):992-1005. DOI: 10.1046/j.1365-2168.2000.01513.x. View

Fujita Y, Krause G, Scheffner M, Zechner D, Leddy H, Behrens J . Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol. 2002; 4(3):222-31. DOI: 10.1038/ncb758. View

Hajra K, Fearon E . The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 2002; 62(6):1613-8. View

Jacobs J, van Lohuizen M . Polycomb repression: from cellular memory to cellular proliferation and cancer. Biochim Biophys Acta. 2002; 1602(2):151-61. DOI: 10.1016/s0304-419x(02)00052-5. View

Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A . Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3(7):RESEARCH0034. PMC: 126239. DOI: 10.1186/gb-2002-3-7-research0034. View

Varambally S, Dhanasekaran S, Zhou M, Barrette T, Kumar-Sinha C, Sanda M . The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002; 419(6907):624-9. DOI: 10.1038/nature01075. View

10.

Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P . Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science. 2002; 298(5595):1039-43. DOI: 10.1126/science.1076997. View

11.

Plath K, Fang J, Mlynarczyk-Evans S, Cao R, Worringer K, Wang H . Role of histone H3 lysine 27 methylation in X inactivation. Science. 2003; 300(5616):131-5. DOI: 10.1126/science.1084274. View

12.

Rhodes D, Sanda M, Otte A, Chinnaiyan A, Rubin M . Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. J Natl Cancer Inst. 2003; 95(9):661-8. DOI: 10.1093/jnci/95.9.661. View

13.

Hirohashi S, Kanai Y . Cell adhesion system and human cancer morphogenesis. Cancer Sci. 2003; 94(7):575-81. PMC: 11160151. DOI: 10.1111/j.1349-7006.2003.tb01485.x. View

14.

Kleer C, Cao Q, Varambally S, Shen R, Ota I, Tomlins S . EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A. 2003; 100(20):11606-11. PMC: 208805. DOI: 10.1073/pnas.1933744100. View

15.

Peinado H, Ballestar E, Esteller M, Cano A . Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol. 2003; 24(1):306-19. PMC: 303344. DOI: 10.1128/MCB.24.1.306-319.2004. View

16.

Kirmizis A, Bartley S, Kuzmichev A, Margueron R, Reinberg D, Green R . Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev. 2004; 18(13):1592-605. PMC: 443521. DOI: 10.1101/gad.1200204. View

17.

Takeno S, Noguchi T, Fumoto S, Kimura Y, Shibata T, Kawahara K . E-cadherin expression in patients with esophageal squamous cell carcinoma: promoter hypermethylation, Snail overexpression, and clinicopathologic implications. Am J Clin Pathol. 2004; 122(1):78-84. DOI: 10.1309/P2CD-FGU1-U7CL-V5YR. View

18.

Haybittle J, Blamey R, Elston C, Johnson J, DOYLE P, Campbell F . A prognostic index in primary breast cancer. Br J Cancer. 1982; 45(3):361-6. PMC: 2010939. DOI: 10.1038/bjc.1982.62. View

19.

Damsky C, Richa J, Solter D, Knudsen K, Buck C . Identification and purification of a cell surface glycoprotein mediating intercellular adhesion in embryonic and adult tissue. Cell. 1983; 34(2):455-66. DOI: 10.1016/0092-8674(83)90379-3. View

20.

Rosen P, Groshen S . Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0). Assessment of 644 patients with median follow-up of 18 years. Surg Clin North Am. 1990; 70(4):937-62. DOI: 10.1016/s0039-6109(16)45190-x. View